March 14 Product: BMSs Breyanzi Indications: chronic lymphocytic leukemia and small lymphocytic leukemia As Bristol Myers Squibb made final preparations for Fridays advisory committee meeting on its CAR-T therapy Abecma, the company got an early win in the same drug class
38 This will test whether people with obesity plus heart failure with preserved ejection fraction, randomised to tirzepatide or placebo for 52 weeks, improve a composite endpoint of mortality, heart failure events, exercise capacity, and heart failure symptoms
Part 2: What are the common side effects of these medications
Horowitz M, Cook DJ, Collins PJ et al (1982) Measurement of gastric emptying after gastric bypass surgery using radionuclides
What to eat on tirzepatide matters enormously for body composition outcomes, and no additive in the world can compensate for a protein-deficient diet and a sedentary lifestyle during rapid weight loss